February 17, 2020 Issue | Chemical & Engineering News

The key to knowledge is in your (nitrile-gloved) hands

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

February 17, 2020 Cover

Volume 98, Issue 7

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

Cover image:A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

Credit: C&EN/Protein Data Bank, PDB ID 3JBL (NLRP3); Protein Data Bank, PDB ID 6CB8 (gasdermin-D)

Full Article

Volume 98 | Issue 7

« Prev

Robert Cichewicz, professor, University of Oklahoma

Consumer Products

Why chemical makers love the cleaning product industry

Innovation, fast-paced change, and products that go down the drain give the sector its enduring appeal
Employment

Is it OK to renege on an offer letter?

Chemjobber on what you shouldn’t accept unless you’re sure you want the job
Sponsored Content
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime